
EMBIO Diagnostics is a tech company based in Nicosia, Cyprus, specializing in innovative, portable diagnostic devices that leverage Artificial Intelligence and Machine Learning. Their flagship products, B.EL.D™ and airbeld™, serve various industries including food safety, healthcare, and environmental monitoring. B.EL.D™ is a multi-purpose portable chemical analyzer, while airbeld™ monitors indoor air quality in real-time. With a commitment to quality and innovation, EMBIO Diagnostics aims to provide rapid, accurate results to enhance safety and efficiency across sectors.

EMBIO Diagnostics is a tech company based in Nicosia, Cyprus, specializing in innovative, portable diagnostic devices that leverage Artificial Intelligence and Machine Learning. Their flagship products, B.EL.D™ and airbeld™, serve various industries including food safety, healthcare, and environmental monitoring. B.EL.D™ is a multi-purpose portable chemical analyzer, while airbeld™ monitors indoor air quality in real-time. With a commitment to quality and innovation, EMBIO Diagnostics aims to provide rapid, accurate results to enhance safety and efficiency across sectors.
Headquarters: Nicosia, Cyprus
Founded: 2016
Core products: B.EL.D™ portable chemical analyzer; airbeld™ indoor air quality monitor
Industry: Biotechnology / deep-tech diagnostics
Notable investors: ASBIS Group, KV Fund, Kinisis Ventures
| Company |
|---|
Rapid, on-site detection and monitoring for food safety, environmental monitoring, maritime and healthcare applications.
2016
Biotechnology
€1,000,000
Strategic investment announced to support R&D and international expansion.
Company announced a new investment round led by KV Fund; amount not disclosed in company release.
“Company has strategic and VC backing from ASBIS Group, KV Fund and Kinisis Ventures”